Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

CroatiaBack to Croatia

Clinical trials in Split – page 4

65 clinical trials in Split, Croatia across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

CroatiaOur site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)
Split at a glance
65
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

65 trials in Split

Open in trial search

Squamous cell carcinoma of head and neck

Not recruiting

Study of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease

Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Genmab A/S

Neovascular age-related macular degeneration

Not recruiting

Study of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Opthea Limited

Pulmonary arterial hypertension

Not recruiting

Study of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Sotatercept
  • Sponsor:Acceleron Pharma Inc.

Pulmonary arterial hypertension

Not recruiting

Long-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)

InvestigationalNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Sotatercept
  • Sponsor:Acceleron Pharma Inc.

Bipolar disorder

Not recruiting

Study on Lumateperone for Treating Manic Episodes in Bipolar I Disorder Patients

Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Lumateperone
  • Sponsor:Intra-Cellular Therapies Inc.

Relapsing-remitting multiple sclerosis

Not recruiting

Study on the Safety and Effectiveness of Ocrelizumab vs. Fingolimod for Children and Adolescents with Relapsing-Remitting Multiple Sclerosis

Registered drug
Countries:CroatiaCroatia
  • Participants:0–17 years
  • Substances:Dimenhydrinate
  • Sponsor:F. Hoffmann-La Roche AG

Urinary tract infection

Not recruiting

Title: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis

Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Cilastatin
  • Sponsor:Spero Therapeutics Inc.

Alopecia areata

Not recruiting

Study on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata

Investigational
Countries:CroatiaCroatia
  • Participants:0–17 years · 18–64 years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Diffuse large B-cell lymphoma

Not recruiting

Study on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on the Effects of Navitoclax and Ruxolitinib for Patients with Myelofibrosis

Not recruiting
Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Navitoclax
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

B-cell lymphoma+1

Not recruiting

Study on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma

Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn's Disease

Not recruiting
Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International

Other cities in Croatia

The busiest research cities in the country

All 26 cities in Croatia

Clinical research in Split

What the registry says about research in the country

01 Autoimmune Conditions

Innovative research focusing on autoimmune disorders including trials for new treatments of Sjögren's Syndrome, Systemic Lupus Erythematosus, and Psoriatic Arthritis. Studies are evaluating novel therapeutic approaches to manage symptoms and improve patient outcomes.

  • Systemic Sclerosis Treatment
  • Lupus Nephritis Management
  • Immunological Response Studies
02 Inflammatory Diseases

Comprehensive research into inflammatory conditions, with trials examining treatments for Crohn's Disease and Ulcerative Colitis. Studies are investigating combination therapies and long-term maintenance treatments to improve disease management.

  • Gastrointestinal Disorders
  • Dermatological Conditions
  • Novel Treatment Approaches
03 Neurological Disorders

Advanced clinical trials exploring treatments for Multiple Sclerosis, with studies comparing the efficacy of new medications against established therapies. Research includes both adult and pediatric populations with relapsing-remitting forms of the disease.

  • MS Treatment Innovations
  • Pediatric MS Studies
  • Disease Modification Research
04 Oncology Research

Cutting-edge studies in cancer treatment, including trials for breast cancer and multiple myeloma. Research focuses on targeted therapies and novel treatment combinations to improve patient outcomes.

  • Hematological Malignancies
  • Breast Cancer Therapies
  • Targeted Treatment Approaches
Back to CroatiaAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.